HLA-DOB Antikörper (FITC)
Kurzübersicht für HLA-DOB Antikörper (FITC) (ABIN2606261)
Target
Alle HLA-DOB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- HLA-DOB
-
Aufreinigung
- Protein G purified
-
Immunogen
-
C-terminal peptide from human HLA-DOB, HLA class II.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: ELISA, WB
Usage: This antibody is suitable for use in Western Blot and ELISA. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.02 % sodium azide, EIA grade BSA.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- HLA-DOB (Major Histocompatibility Complex, Class II, DO beta (HLA-DOB))
-
Andere Bezeichnung
- HLA-DOB
-
Hintergrund
-
Name/Gene ID: HLA-DOB
Synonyms: HLA-DOB, DOB, MHC class II antigen DOB -
Gen-ID
- 3112
-
Pathways
- Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-